A multiantigen vaccine targeting neu, IGFBP-2, and IGF-IR prevents tumor progression in mice with preinvasive breast disease.
about
Cancer vaccinesElimination of IL-10-inducing T-helper epitopes from an IGFBP-2 vaccine ensures potent antitumor activity.The antigenic repertoire of premalignant and high-risk lesions.Designing vaccines to prevent breast cancer recurrence or invasive disease.IGFBP-2 and -5: important regulators of normal and neoplastic mammary gland physiologyIGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas.The hallmarks of premalignant conditions: a molecular basis for cancer preventionRetinoids and rexinoids in cancer prevention: from laboratory to clinic.The Antitumor Efficacy of IL2/IL21-Cultured Polyfunctional Neu-Specific T Cells Is TNFα/IL17 Dependent.Transforming Cancer Prevention through Precision Medicine and Immune-oncology.Deregulation of IGF-binding proteins -2 and -5 contributes to the development of endocrine resistant breast cancer in vitro.Retired self-proteins as vaccine targets for primary immunoprevention of adult-onset cancers.Cancer Prevention: Lessons Learned and Future Directions.Epidermal growth factor receptor derived peptide vaccination to prevent lung adenocarcinoma formation: An in vivo study in a murine model of EGFR mutant lung cancer.Redirecting the focus of cancer immunotherapy to premalignant conditions.Current modalities in cancer immunotherapy: Immunomodulatory antibodies, CARs and vaccines.IGF-1R peptide vaccines/mimics inhibit the growth of BxPC3 and JIMT-1 cancer cells and exhibit synergistic antitumor effects with HER-1 and HER-2 peptides.Vaccination with ErbB-2 peptides prevents cancer stem cell expansion and suppresses the development of spontaneous tumors in MMTV-PyMT transgenic mice.Immunization against HIF-1α Inhibits the Growth of Basal Mammary Tumors and Targets Mammary Stem Cells In Vivo.A pilot study of the immunogenicity of a 9-peptide breast cancer vaccine plus poly-ICLC in early stage breast cancer.Immunoprevention of KRAS-driven lung adenocarcinoma by a multipeptide vaccine.Could immunosignatures technology enable the development of a preventative cancer vaccine?Construction of recombinant Mip-FlaA dominant epitope vaccine against Legionella pneumophila and evaluation of the immunogenicity and protective immunity.Breast Cancer Prevention: Current Approaches and Future Directions
P2860
Q27024438-0131BF08-93A8-41BF-A773-B2113BEF24E1Q33679779-DF93B836-BD39-4903-82DD-DD4ED3EF38CCQ35251460-0995190B-8CE1-4BB1-9556-0041F811EFE3Q35546337-B852CCA8-8A71-40F6-8722-07730DE16210Q35690638-EC36690D-AA2F-4D53-B056-DE8A9585F4D2Q35690979-452FD0D1-C591-48E5-BFCA-97A5B60F9D82Q36679858-470E7F19-121A-41D9-A550-207A2FDCB9E4Q36680198-94F945C8-DC38-4428-BE60-9B8905708A95Q36863278-0A7EF916-9B21-4993-939A-95C8D9DD98E0Q37114360-8F997B5A-CA5A-46E4-9C10-BDF080C57074Q37362627-5EB169BA-D18C-4138-B98C-9BCA00148191Q38244698-23FEC64D-BECC-491E-987C-52A67391B77CQ38652183-15BF9CB8-985C-4C73-BFD2-50A6AA1AF41FQ38837187-56860CA9-75EB-44AB-AABB-D742F28BE4C4Q39107022-F73A7BE7-9F75-403E-A7BC-26F1329F5D41Q39189908-D1DA0F11-EF98-477B-B38C-0412F0841E4CQ42107855-2B5345C9-BAF2-4DEB-84DD-608424E0B430Q42201182-C2E911EB-CAEE-4959-917A-F2F9383913F6Q42503675-6FFCE180-0245-4FFC-BFA7-3EEB3DA80E45Q45073466-C53E0F3F-8B96-4358-A98B-EF891E6DA592Q47099526-0C211297-92B9-473B-9281-81F04EDD2AB8Q51519843-19C18770-A07B-49DB-BEAD-093E49E3433FQ51629724-B915D388-07C4-4117-8405-1ECEBE7B72E1Q57113892-B37FCA01-7080-47F2-92BF-8D7FB0C89F31
P2860
A multiantigen vaccine targeting neu, IGFBP-2, and IGF-IR prevents tumor progression in mice with preinvasive breast disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A multiantigen vaccine targeti ...... th preinvasive breast disease.
@en
A multiantigen vaccine targeti ...... th preinvasive breast disease.
@nl
type
label
A multiantigen vaccine targeti ...... th preinvasive breast disease.
@en
A multiantigen vaccine targeti ...... th preinvasive breast disease.
@nl
prefLabel
A multiantigen vaccine targeti ...... th preinvasive breast disease.
@en
A multiantigen vaccine targeti ...... th preinvasive breast disease.
@nl
P2093
P2860
P1476
A multiantigen vaccine targeti ...... th preinvasive breast disease.
@en
P2093
Daniel R Herendeen
Denise L Cecil
Kyong Hwa Park
Mary L Disis
Megan M O'Meara
Piper M Treuting
Ronald A Lubet
Vy Phan- Lai
P2860
P304
P356
10.1158/1940-6207.CAPR-13-0182
P577
2013-10-23T00:00:00Z